Vanguard Portfolio Management
EVMN

Vanguard Portfolio Management’s Evommune Inc EVMN Stock Holding History

Vanguard Portfolio Management’s Portfolio EVMN Stock Details EVMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.59M Buy
119,927
+58,934
+97% +$1.37M ﹤0.01% 2821
2026
Q1 		$1.4M Buy
+60,993
New +$1.38M ﹤0.01% 2693

Other funds holding EVMN

EFM
EQT Fund Management Luxembourg $863M AUM 26.03% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $308M AUM 120.89% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Vanguard Portfolio Management's EVMN Position: Q2 2026 in Review

Vanguard Portfolio Management increased its Evommune Inc (EVMN) stake by 97% in Q2 2026, buying an estimated $1.37M and bringing the position to 119,927 shares worth $1.59M. The position accounts for ﹤0.01% of the portfolio, ranked #2821.

Vanguard Portfolio Management first reported a position in EVMN in Q1 2026 and has held it in 2 quarters since. 104 funds tracked by Wall St. Rank hold EVMN as of Q2 2026.

  • Vanguard Portfolio Management held 119,927 shares of Evommune Inc worth $1.59M as of Q2 2026.
  • Vanguard Portfolio Management bought 58,934 Evommune Inc shares in Q2 2026, an estimated $1.37M.
  • Evommune Inc made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #2821 holding.
  • Vanguard Portfolio Management first reported a position in Evommune Inc in Q1 2026 and has held it in 2 quarters since.
  • 104 funds tracked by Wall St. Rank held Evommune Inc as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.